サマリー

エリスロポエチン刺激薬の世界市場 2022-2026 年
Technavioはエリスロポエチン刺激剤市場を監視しており、2022-2026年の間に4.74億ドル、予測期間中にCAGR8.9％で加速して成長すると予測しています。当レポートでは、エリスロポエチン刺激剤市場の全体分析、市場規模・予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、CKD患者の大規模なプールの存在、HIV感染症や末期腎不全における用途の増加、血栓症のリスク、手術中、純赤血球無形成症によって牽引されています。
エリスロポエチン刺激剤市場の分析には、タイプ別セグメントと地理的状況が含まれます。
Technavioのエリスロポエチン刺激剤市場は、以下のようにセグメント化されています。
タイプ別
- エポエチンアルファ
- エポエチンベータ
- ダルベポエチンアルファ
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、発展途上国におけるCKD透析センター数の増加が、今後数年間のエリスロポエチン製剤市場の成長を促進する主要因の1つであると見ています。また、ベンダー間の戦略的提携の事例が増加していることや、パイプラインにある薬剤の数が増加していることも、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。エリスロポエチン刺激剤市場に関する当レポートの対象領域は以下の通りです。
- エリスロポエチン刺激薬の市場サイジング
- エリスロポエチン製剤の市場予測
- エリスロポエチン刺激剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、3SBio Inc.、Akebia Therapeutics Inc.、Amgen Inc.を含むいくつかの主要エリスロポエチン刺激剤市場ベンダーについて詳細に分析しています。Biocon Ltd.、Biosidus SA、Dr. Reddys Laboratories Ltd.、F. Hoffmann La Roche Ltd.、Johnson and Johnson、LG Chem Ltd.、Nanogen Pharmaceutical Biotechnology、Novartis AG、Pfizer Inc、Pieris Pharmaceuticals Inc、Reliance Industries Ltd.、Thermo Fisher Scientific Inc、およびZydus Lifesciences Ltd. などの大手ベンダーについて詳細な分析を提供しています。また、エリスロポエチン刺激剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/erythropoietin-stimulating-agents-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Epoetin alfa - Market size and forecast 2021-2026
o Exhibit 28: Chart on Epoetin alfa - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Epoetin alfa - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Epoetin alfa - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Epoetin alfa - Year-over-year growth 2021-2026 (%)
o 5.4 Epoetin beta - Market size and forecast 2021-2026
o Exhibit 32: Chart on Epoetin beta - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Epoetin beta - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Epoetin beta - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Epoetin beta - Year-over-year growth 2021-2026 (%)
o 5.5 Darbepoetin alfa - Market size and forecast 2021-2026
o Exhibit 36: Chart on Darbepoetin alfa - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Darbepoetin alfa - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Darbepoetin alfa - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Darbepoetin alfa - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Type
o Exhibit 44: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Akebia Therapeutics Inc.
o Exhibit 93: Akebia Therapeutics Inc. - Overview
o Exhibit 94: Akebia Therapeutics Inc. - Product / Service
o Exhibit 95: Akebia Therapeutics Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 96: Amgen Inc. - Overview
o Exhibit 97: Amgen Inc. - Product / Service
o Exhibit 98: Amgen Inc. - Key offerings
o 10.5 Biocon Ltd.
o Exhibit 99: Biocon Ltd. - Overview
o Exhibit 100: Biocon Ltd. - Business segments
o Exhibit 101: Biocon Ltd. - Key offerings
o Exhibit 102: Biocon Ltd. - Segment focus
o 10.6 Biosidus SA
o Exhibit 103: Biosidus SA - Overview
o Exhibit 104: Biosidus SA - Product / Service
o Exhibit 105: Biosidus SA - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 106: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 107: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 108: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 109: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 110: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Johnson and Johnson
o Exhibit 111: Johnson and Johnson - Overview
o Exhibit 112: Johnson and Johnson - Business segments
o Exhibit 113: Johnson and Johnson - Key news
o Exhibit 114: Johnson and Johnson - Key offerings
o Exhibit 115: Johnson and Johnson - Segment focus
o 10.9 Nanogen Pharmaceutical Biotechnology
o Exhibit 116: Nanogen Pharmaceutical Biotechnology - Overview
o Exhibit 117: Nanogen Pharmaceutical Biotechnology - Product / Service
o Exhibit 118: Nanogen Pharmaceutical Biotechnology - Key offerings
o 10.10 Novartis AG
o Exhibit 119: Novartis AG - Overview
o Exhibit 120: Novartis AG - Business segments
o Exhibit 121: Novartis AG - Key offerings
o Exhibit 122: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 123: Pfizer Inc. - Overview
o Exhibit 124: Pfizer Inc. - Product / Service
o Exhibit 125: Pfizer Inc. - Key news
o Exhibit 126: Pfizer Inc. - Key offerings
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 127: Thermo Fisher Scientific Inc. - Overview
o Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 129: Thermo Fisher Scientific Inc. - Key news
o Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 132: Inclusions checklist
o Exhibit 133: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 134: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 135: Research methodology
o Exhibit 136: Validation techniques employed for market sizing
o Exhibit 137: Information sources
o 11.5 List of abbreviations
o Exhibit 138: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Epoetin alfa - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Epoetin alfa - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Epoetin alfa - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Epoetin alfa - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Epoetin beta - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Epoetin beta - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Epoetin beta - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Epoetin beta - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Darbepoetin alfa - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Darbepoetin alfa - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Darbepoetin alfa - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Darbepoetin alfa - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Akebia Therapeutics Inc. - Overview
Exhibits94: Akebia Therapeutics Inc. - Product / Service
Exhibits95: Akebia Therapeutics Inc. - Key offerings
Exhibits96: Amgen Inc. - Overview
Exhibits97: Amgen Inc. - Product / Service
Exhibits98: Amgen Inc. - Key offerings
Exhibits99: Biocon Ltd. - Overview
Exhibits100: Biocon Ltd. - Business segments
Exhibits101: Biocon Ltd. - Key offerings
Exhibits102: Biocon Ltd. - Segment focus
Exhibits103: Biosidus SA - Overview
Exhibits104: Biosidus SA - Product / Service
Exhibits105: Biosidus SA - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Overview
Exhibits107: F. Hoffmann La Roche Ltd. - Business segments
Exhibits108: F. Hoffmann La Roche Ltd. - Key news
Exhibits109: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits110: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits111: Johnson and Johnson - Overview
Exhibits112: Johnson and Johnson - Business segments
Exhibits113: Johnson and Johnson - Key news
Exhibits114: Johnson and Johnson - Key offerings
Exhibits115: Johnson and Johnson - Segment focus
Exhibits116: Nanogen Pharmaceutical Biotechnology - Overview
Exhibits117: Nanogen Pharmaceutical Biotechnology - Product / Service
Exhibits118: Nanogen Pharmaceutical Biotechnology - Key offerings
Exhibits119: Novartis AG - Overview
Exhibits120: Novartis AG - Business segments
Exhibits121: Novartis AG - Key offerings
Exhibits122: Novartis AG - Segment focus
Exhibits123: Pfizer Inc. - Overview
Exhibits124: Pfizer Inc. - Product / Service
Exhibits125: Pfizer Inc. - Key news
Exhibits126: Pfizer Inc. - Key offerings
Exhibits127: Thermo Fisher Scientific Inc. - Overview
Exhibits128: Thermo Fisher Scientific Inc. - Business segments
Exhibits129: Thermo Fisher Scientific Inc. - Key news
Exhibits130: Thermo Fisher Scientific Inc. - Key offerings
Exhibits131: Thermo Fisher Scientific Inc. - Segment focus
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations